Clinical Trial: Extreme Phenotypes to Identify Susceptibility of Patients Living With Type 2 to Diabetes Related Complications

U.S., Nov. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07250607) titled 'Extreme Phenotypes to Identify Susceptibility of Patients Living With Type 2 to Diabetes Related Complications' on Nov. 17.

Brief Summary: The goal of this observational study is to learn more about the diverse susceptibility to micro and macrovascular complications in individuals living with Type 2 Diabetes (T2D).

The main questions of the study are:

* Is the chronic exposure to hyperglycemia the only determinant of diverse susceptibility to diabetes related complications (DRC) across the T2D population?

* Is it possible to develop a reliable tool to identify patients at different susceptibility to DRC?

* Is it possible to pred...